Osmanodja, B.; Akifova, A.; Oellerich, M.; Beck, J.; Bornemann-Kolatzki, K.; Schütz, E.; Budde, K.
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study. J. Clin. Med. 2023, 12, 2437.
https://doi.org/10.3390/jcm12062437
AMA Style
Osmanodja B, Akifova A, Oellerich M, Beck J, Bornemann-Kolatzki K, Schütz E, Budde K.
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study. Journal of Clinical Medicine. 2023; 12(6):2437.
https://doi.org/10.3390/jcm12062437
Chicago/Turabian Style
Osmanodja, Bilgin, Aylin Akifova, Michael Oellerich, Julia Beck, Kirsten Bornemann-Kolatzki, Ekkehard Schütz, and Klemens Budde.
2023. "Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study" Journal of Clinical Medicine 12, no. 6: 2437.
https://doi.org/10.3390/jcm12062437
APA Style
Osmanodja, B., Akifova, A., Oellerich, M., Beck, J., Bornemann-Kolatzki, K., Schütz, E., & Budde, K.
(2023). Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study. Journal of Clinical Medicine, 12(6), 2437.
https://doi.org/10.3390/jcm12062437